Medicine & Life Sciences
2,3,7,7a-tetrahydro-3-hydroxy-7-methyl-2-(prop-1-en-1-yl)-5H-furo(3,4-b)pyran-5-one
13%
3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
15%
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
22%
A549 Cells
13%
Acetylation
20%
Acute Myeloid Leukemia
12%
Ankylosing Spondylitis
15%
Anti-Inflammatory Agents
12%
Antibodies
13%
Antimitotic Agents
13%
Antineoplastic Agents
37%
Apoptosis
50%
Aryl Hydrocarbon Receptors
17%
Autophagy
27%
Benzamides
12%
Binding Sites
12%
Breast Neoplasms
25%
Calcium
13%
Caspase 3
12%
Cell Death
21%
Cell Line
26%
Cell Movement
24%
Cell Proliferation
17%
Cell Survival
11%
Cisplatin
12%
Cohort Studies
12%
Colchicine
11%
Colorectal Neoplasms
36%
Computational Biology
11%
Coronary Vessels
11%
Cyclooxygenase 2
16%
denbinobin
27%
DNA Damage
13%
Down-Regulation
27%
ErbB Receptors
12%
fosbretabulin
12%
Gene Expression
21%
Genes
29%
Genetic Polymorphisms
12%
Glioblastoma
39%
Glioma
17%
Growth
41%
Heterografts
26%
hispidulin
23%
Histone Deacetylase 6
21%
Histone Deacetylase Inhibitors
100%
Histone Deacetylases
55%
Histones
14%
HSP90 Heat-Shock Proteins
12%
Human Activities
11%
Human Umbilical Vein Endothelial Cells
14%
Hydroxamic Acids
18%
Hypoxia-Inducible Factor 1
16%
In Vitro Techniques
37%
indoline
19%
Inflammation
11%
Inhibitory Concentration 50
45%
Intravenous Immunoglobulins
18%
Lipopolysaccharides
13%
Lung Neoplasms
24%
Matrix Metalloproteinase 9
11%
Messenger RNA
14%
Microtubules
28%
MPT0B098
13%
MPT0L145
13%
Mucocutaneous Lymph Node Syndrome
48%
Nanoparticles
17%
Neoplasm Metastasis
16%
Neoplasms
74%
Non-Small Cell Lung Carcinoma
27%
Osteoporosis
11%
osthol
27%
Pancreatic Neoplasms
13%
Pharmaceutical Chemistry
13%
Pharmaceutical Preparations
29%
Phosphatidylinositol 3-Kinases
12%
Phosphorylation
28%
Phosphotransferases
13%
Polymerization
12%
Population
26%
Prostatic Neoplasms
11%
Protein Isoforms
14%
Proteins
36%
quinoline
14%
Reactive Oxygen Species
18%
shikonin
12%
Single Nucleotide Polymorphism
21%
Stromal Interaction Molecule 1
17%
Taiwan
40%
Temozolomide
24%
Therapeutics
30%
Transforming Growth Factors
12%
Triple Negative Breast Neoplasms
17%
Tubulin
35%
Tubulin Modulators
32%
Up-Regulation
16%
Vorinostat
18%
Western Blotting
14%
WMJ-S-001
13%
Chemical Compounds
50 Percent Growth Inhibition
14%
Acetylation
12%
Alkannin
6%
Anilide
7%
Antigen
7%
Antiinflammatory
6%
Antimitotic
5%
Antimitotic Agent
6%
Antineoplastic Agent
30%
Antioxidant Agent
10%
Antiproliferative
35%
Antitumor
22%
Antivascular
5%
Apoptotic
17%
Aporphine
5%
Application
7%
Benzamide
5%
Binding Site
9%
Bioactivity
8%
Bioavailability
11%
Biological Marker
7%
Calcium(0)
9%
Cantharidin
6%
Cell Death
14%
Cell Viability
9%
Chemistry
6%
Chemoattractant
5%
Chidamide
6%
Clearance
5%
Cleavage
7%
Colchicine
14%
Disorder
9%
Dose
9%
Drug
34%
Drug Target
5%
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
5%
Enzyme Activity
5%
Flavonoid
8%
Flow
7%
Genetic Polymorphism
22%
Genotoxic
5%
Genotoxicity
11%
Glucose
5%
Glycol
9%
Growth Inhibition
9%
Haematological
5%
Heat
6%
Hispidulin
12%
Histone
65%
Hydrocarbon
7%
Hydroxamic Acid
24%
Indoline
5%
Lipid
5%
Lipopolysaccharide
8%
Marker
7%
Membrane Potential
8%
Messenger RNA
5%
Metabolic
7%
Metabolite
13%
Microtubule-Destabilising Agent
5%
Modification
8%
Molecule
8%
Nanocarrier
10%
Nanoparticle
6%
Occurrence in Nature
7%
Osthole
14%
Oxidative Stress
8%
Pharmacokinetics
10%
Pharmacological Metabolism
8%
Phosphotransferase Inhibitor
9%
Plasma
6%
Poly(ethylene Glycol)
5%
Polymerization Reaction
13%
Proliferative
5%
Protective
8%
Protein
50%
Reactive Oxygen Metabolite
19%
Resistance
14%
Retinal
13%
Retinal Pigment
8%
Shikonin
8%
Structure-Activity Relationship
9%
Substitution Reaction
5%
Superoxide
6%
Temozolomide
14%
Total Synthesis
7%
Tyrosine
6%
Vascular Targeting Agent
9%
Vorinostat
7%
Weight
6%
Western Blotting
9%